Market Overview

Analysts Weigh In On The FDA's Position On E-Cigarettes, Menthols

Share:
Analysts Weigh In On The FDA's Position On E-Cigarettes, Menthols

The Food and Drug Administration is set on introducing restrictions on the sale of electronic cigarettes, including prohibiting most flavored products in convenience stores and gas stations, The Washington Post reported Nov. 8. The Wall Street Journal followed up with its own report Friday that said the FDA could propose a ban on menthol cigarettes.

Height Securities' Stefanie Miller and Wells Fargo's Bonnie Herzog commented on recent media reports in separate research reports.

Height Says Concerns Overblown

The FDA has the authority to regulate tobacco products from the Tobacco Control Act of 2009, Miller said in a note.

The FDA could ban flavors of tobacco products, including menthol, but the Act doesn't allow the FDA to tobacco products immediately, according to Height.

A ban on menthol or other tobacco products is unlikely to occur before 2022, and the tobacco industry would likely slow down the enaction of any ban through litigation, Miller said. 

Nevertheless, last week's reports are "unwelcome news" for cigarette companies like British American Tobacco PLC (NYSE: BTI), Imperial Tobacco Group plc (OTC: IMBBY) and Altria Group Inc (NYSE: MO), according to Height. 

Wells Fargo: Who's At Risk?

Wells Fargo's position on menthol is that science doesn't support a point of view that menthol cigarettes are more harmful than non-menthol, Herzog said in a note.

Given the FDA's position that it will follow a science-based approach, it is unlikely the regulatory body will outright ban menthol — although a proposal to restrict or lower the levels of menthol is reasonable, the analyst said. 

Menthol cigarettes account for around 35 percent of total industry volume in the U.S., Herzog said. British American Tobacco's Reynolds brand is the largest in the menthol segment, as 55 percent of its volume in the U.S. is menthol, she said.

Approximately 21 percent of Altria's volume is menthol and it accounts for around 18 percent of total profit, while about 20 percent of Imperial Tobacco's volume is menthol, the analyst said. 

Price Action

British American Tobacco shares were down nearly 3 percent at $36.95 at the time of publication Tuesday, while Altria was down 1.4 percent at $60.34 and Imperial Tobacco was down 1.89 percent at $33.96. Philip Morris (NYSE: PM) was down about 1.5 percent.

Related Links:

Bernstein Initiates On Tobacco Stocks: Philip Morris 'Leads The Way In The New Nicotine World'

Marlboro Maker Altria May Be In Talks With Cannabis Producer Aphria About A Minority Stake

Posted-In: Bonnie Herzog E-CigarettesAnalyst Color News FDA Top Stories Analyst Ratings Media Best of Benzinga

 

Related Articles (BTI + IMBBY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MDRXKeyBancUpgrades0.0
ANETNomuraUpgrades260.0
CNPRBC CapitalUpgrades34.0
FISVOppenheimerUpgrades88.0
FNDUBSUpgrades37.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Hot Stocks Among Short Sellers: Tilray Becoming 'The Tesla Of The Pharma Sector'

Werner CEO Issues Optimistic Outlook For Peak Season, The Year Ahead